Escitil
On the Bulgarian pack: Есцитил 5 mg филмирани таблетки
5 mg · film - coated tablets
- Prescription only
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Escitalopram
- Made by
- Egis Pharmaceuticals PLC
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet read the official leaflet for this product. The exact uses and dose are in the leaflet inside the pack. Open the official leaflet
How it works
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (escitalopram). It describes the substance, not this Bulgarian product — its uses and doses can differ.
The mechanism of antidepressant action of escitalopram, the S-enantiomer of racemic citalopram, is presumed to be linked to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT).
Escitalopram is metabolized to S-DCT and S-didemethylcitalopram (S-DDCT).
Absorption of escitalopram is not affected by food.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-03-19
Safety of the active substance
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (escitalopram). It describes the substance, not this Bulgarian product — its uses and doses can differ.
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS See full prescribing information for complete boxed warning.
- Do not use MAOIs intended to treat psychiatric disorders with escitalopram or within 14 days of stopping treatment with escitalopram.
- Do not use escitalopram within 14 days of stopping an MAOI intended to treat psychiatric disorders.
- The use of escitalopram tablets within 14 days of stopping an MAOI intended to treat psychiatric disorders is also contraindicated [see Dosage and Administration ( 2.7 ) and Warnings and Precautions ( 5.2 )].
Most commonly observed adverse reactions (incidence ≥ 5% and at least twice the incidence of placebo patients) are: insomnia, ejaculation disorder (primarily ejaculatory delay), nausea, sweating increased, fatigue and somnolence, decreased libido, and anorgasmia ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Torrent Pharma Inc. at 1-800-912-9561, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States17 matching products
Spain8 matching products
- CIPRALEX 5 mg escitalopram · comprimido recubierto con película
- ESCITALOPRAM ACCORD 5 MG · comprimido recubierto con película
- ESCITALOPRAM FARMALIDER 5 mg · comprimido recubierto con película
- ESCITALOPRAM GRINDEKS 5 mg · comprimido recubierto con película
- ESCITALOPRAM HEC PHARM 5 mg · comprimido recubierto con película
- ESCITALOPRAM IPCA 5 mg · comprimido recubierto con película
- ESCITALOPRAM TARBIS FARMA 5 mg · comprimido recubierto con película
- ESCITALOPRAM VISO FARMACEUTICA 5 mg · comprimido recubierto con película
Canada11 matching products
Netherlands8 matching products
- Escitalopram 5 mg Teva 5 mg · filmomhulde tablet
- Escitalopram Accord 5 mg filmomhulde tabletten 5 mg · filmomhulde tablet
- Escitalopram Bristol 5 mg filmomhulde tabletten 5 mg · filmomhulde tablet
- Escitalopram Grindeks 5 mg filmomhulde tabletten 5 mg · filmomhulde tablet
- Escitalopram Polpharma 5 mg orodispergeerbare tabletten 5 mg · orodispergeerbare tablet
- Escitalopram Sandoz 5 mg 5 mg · filmomhulde tablet
- Escitalopram Viatris 5 mg 5 mg · filmomhulde tablet
- Lexapro 5 mg 5 mg · filmomhulde tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Egis Pharmaceuticals PLC · Hungary |
|---|---|
| Active substance | Escitalopram |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 5 mg |
| Form | film - coated tablets |
| Pack sizes | 7 · 10 · 14 · 15 · 20 · 28 · 30 · 49 · 50 · 56 · 60 · 84 · 90 · 98 · 100 · 200 · 500 |
| Classification | N06AB10 · Pain, sleep, mood, epilepsy and the brain |
| Name in the register | Есцитил 5 mg филмирани таблетки |
| Reg. no. | 20090353 |
Source: Bulgarian Drug Agency register · 2026-08-01 · not reviewed by a clinician
Източник: Изпълнителна агенция по лекарствата (ИАЛ). The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Other strengths and forms
4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.